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ABSTRACT
The Centers for Disease Control and Prevention (CDC) recommends chlamydia screening in
young women and others who are at risk based on scientific evidence related to the effectiveness
of screening to prevent chlamydial infection. Female patients may visit the emergency
department (ED) with symptoms such as urethritis, abdominal pain, or vaginal spotting. For men,
most complaints are urinary problems, discharge from the penis, and testicular pain. However,
most infected patients are never symptomatic and have no abnormal physical findings.
Therefore, the question that spurred this project was, “Why aren’t asymptomatic patients
screened more often?” Furthermore, “Why are the CDC screening guidelines for chlamydia often
not followed by providers?” The purpose of this evidence-based project was to provide an
educational intervention to health care providers in the Emergency Department (ED) about the
CDC guidelines for chlamydia screening and to encourage them to screen eligible asymptomatic
patients in a Bronx community-based ED. As a result of the educational intervention, there was a
significant improvement of the ED providers’ knowledge of the CDC guidelines; however, the
screening rate remained low. During the period after the educational intervention, the ED
participants did not satisfactorily comply with the CDC guidelines; however, ED participants
consistently demonstrated their willingness to perform the chlamydia screening for eligible
patients. This finding indicates a need for frequent education on the CDC guidelines on the
importance of chlamydia testing to effectively improve the screening rates.
Keywords: chlamydial infection, chlamydia screening, emergency department
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SECTION ONE: INTRODUCTION
With the number of chlamydial infections increasing every year, the impact of the disease
on society has become a great concern for public health care. In 2017, the Centers for Disease
Control and Prevention (CDC; 2017) reported 1.7 million active cases of chlamydia in the
United States, an increase of 22% since 2013. In 2013, the estimated direct lifetime cost of
treatment for chlamydia and associated complications was $516.7 million (Owusu-Edusei et al.,
2013). Two thirds of new chlamydial infections occur among younger persons aged 15–24
years. Females have nearly twice the rate of chlamydia as males (CDC, 2017). Chlamydia is
one of the most common diseases, but it is preventable. Untreated chlamydial infections can
lead to serious complications and potential long-term damage to a woman’s reproductive system.
Chlamydial infection is a public health issue because it is associated with increased rates of
transmission of and susceptibility to other sexually transmitted infections (STIs) such as syphilis,
gonorrhea, human papillomavirus, and human immunodeficiency virus infection.
The chlamydia rate in the Bronx, New York, has remained higher than other New York
City boroughs. According to the New York State Department of Health (2017), in 2017, the
number of chlamydia cases per 100,000 people in the Bronx was 1127.9, while the number for
Manhattan was 939.5, and 358 for Long Island. In 2019, one emergency department (ED) in the
Bronx found eight, 10, and 14 cases of chlamydial infection in March, April, and May,
respectively. Each year, the number of cases of chlamydial infection has increased at that
hospital.
The CDC (2017) guidelines recommend annual chlamydia screening of all sexually
active women aged <25 years, as is screening of older women at increased risk for infection
(e.g., those who have a new sex partner, more than one sex partner, a sex partner with concurrent
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partners, or a sex partner who has a sexually transmitted infection. All pregnant women aged
<25 years and older pregnant women at increased risk should also be screened. Screening of
sexually active men should be considered in clinical settings with a high prevalence of chlamydia
(e.g., adolescent clinics, correctional facilities, and STD clinics) or in populations with high
burden of infection (e.g., men who have sex with men).
Background
Chlamydia trachomatis, also known as chlamydia, is the most common bacterial STI
worldwide. Chlamydia is transmitted from person to person during unprotected sexual contact
with the vagina, penis, mouth, or anus of an infected sexual partner (CDC, 2017). Many
chlamydial infections are asymptomatic. Screening can be the first strategy to early detection
and treatment. The prevalence of chlamydia varies with age, race, gender, ethnicity, and county,
according to national chlamydia surveillance systems (CDC, 2017). Risk factors for infection
include new or multiple sex partners, a history of STIs, presence of another STI, and inconsistent
condom use (Ghanem & Tuddenham, 2017).
Chlamydia screening in women is conducted using urine, endocervical, or vaginal
samples, while for men, the screening method of choice is a urine sample. Screening for
chlamydia in the rectum and pharynx can be performed in persons who are at risk for infection at
those sites. Chlamydia testing can be done in a doctor’s office, a community health clinic, the
health department, or a local Planned Parenthood health center.
The CDC (2017) recommends azithromycin as primary therapy for the treatment of
uncomplicated genital chlamydial infections. Single-dose therapy of one-gram oral azithromycin
is the first choice of antibiotic for all patients, including pregnant women. Sex partners of those
infected should get treated to prevent re-infection of the original patient. Untreated chlamydial
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infections can lead to serious complications such as urethritis, cervicitis, pelvic inflammatory
disease (PID), ectopic pregnancy, and potential long-term damage to a woman’s reproductive
system, including infertility (Menon et al., 2015). Untreated chlamydia in pregnant women can
lead to an increased risk of preterm delivery (CDC, 2016), as well as ophthalmia neonatorum
(conjunctivitis) and pneumonia in the newborn (CDC, 2017). For men, chlamydial infection can
cause urethritis, acute epididymitis, chronic prostatitis, reactive arthritis (CDC, 2017), and male
infertility (Redgrove & McLaughlin, 2014).
Problem Statement
Even though chlamydia screening has improved over the past decade, lack of awareness
of the CDC guidelines among health care providers is still an important concern. The screening
rates for Chlamydia trachomatis among young women who have no sexually transmitted disease
(STD)-related symptoms in the ED remain low despite the recommendations of screening by the
CDC.
Currently, the rate of chlamydial infection in the Bronx is a growing problem. The
evidence shows that screening asymptomatic patients in the ED who meet the CDC criteria has
been an effective method for reducing chlamydial infection.
Purpose of the Project
The purpose of this scholarly project was to increase providers’ understanding of the
CDC guidelines for chlamydia screening and increase screening rates in asymptomatic patients
in the ED. The ED would be a good place for STD screening to identify undiagnosed infections,
especially for those patients who meet the CDC criteria for screening and are currently
asymptomatic. Testing in the ED will increase early identification and facilitate treatment of
diagnosed patients and their sexual partners.
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Clinical Question
For health care providers located in an urban ED, does an educational intervention
focusing on the CDC guidelines for screening for chlamydia, compared to current knowledge on
screening, lead to increased overall knowledge and increased screening rates for chlamydia in
asymptomatic patients in the ED?
SECTION TWO: LITERATURE REVIEW
Search Strategy
The main search engines used were the Cumulative Index of Nursing and Allied Health
Literature, PubMed, and ProQuest Nursing and Allied Health Database. The key words searched
were chlamydial infection, chlamydial screening, and emergency department. The search was
limited to full-text research studies, the English language, and the years 2013–2019. The search
strategy identified a total of 102 references, but the articles were narrowed based on the quality
of the literature, relevance to alternative areas of screening, type of study, and published date.
Ultimately, the search yielded 29 related articles which were used for the literature review.
Critical Appraisal
Each article was reviewed using a summary and synthesis tool and examined for levels of
evidence according to Melnyk’s Level of Evidence (Melnyk & Fineout-Overholt, 2005). The
literature findings included systematic reviews, clinical practice guidelines, controlled trials,
mixed-method studies, and observational studies which pertained to chlamydia testing and the atrisk, uninsured population. The CDC guidelines for screening of chlamydia are scientific,
evidence-based recommendations developed by the workgroup’s research, a second independent
panel of public health and clinical experts’ review, and other professional organizations (CDC,
2015). Explanations of the ratings and of the strength of evidence are given in Appendix A.
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All studies included in the evidence table (Appendix A) were published in peer-reviewed
literature. The main purpose of most studies was to identify the prevalence of chlamydial
infection in the young female population, assess providers’ understanding of the CDC guidelines
for chlamydia screening, or increase screening rates in asymptomatic patients in EDs. The
majority of studies (n = 24, 82.8%) were conducted in the United States. Several studies (n = 8,
27.6%) reported data relating to EDs. However, the results reported within the systemic reviews
with meta-analyses were consistent with the data from the ED studies. Studies have detailed the
lack of translation of the CDC guidelines into clinical practice (Carlson, Tschann,
Santibenchakul, Hurwitz, & Salcedo, 2017; Goyal, Witt, Hayes, Zaoutis, & Gerber, 2014).
These studies were retrospective chart reviews, but they extensively discussed the importance of
physicians’ adherence to the CDC guidelines. Only three of the 26 randomized controlled trials
(RCTs) reported that a similar intervention provided an effective outcome. Sixteen studies
provided detailed information for chlamydia prevalence within specific demographics (two level
I and one level IV), physician nonadherence (two level V and one level IV), the relationships of
chlamydia and PID and infertility (four level I and one level V), and interventions to increase
screening (three level III, two level IV). The CDC guidelines are significant because they are
backed by evidence. One RCT study conducted in France did not provide sufficient information
about the findings because the research is still in progress. Two studies had limited scientific
methods which resulted in low quality.
Synthesis
Most chlamydial infections are asymptomatic in both women and men (CDC, 2015;
Morhason-Bello et al., 2014). Because of the resultant outcome of untreated chlamydia, the
importance of effective STD screening to identify early chlamydial infection was evident in the
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literature (Anaene, Soyemi, & Caskey, 2016; CDC, 2015). These studies indicated that the
screening for asymptomatic patients should become a standard in today’s evidence-based
practice (EBP). Screening offers an important and promising adjunct for patients’ sexual health.
By screening, providers can be sure they are basing important treatment decisions on evidence
and that they are providing the best care. Clearly, implementation of asymptomatic STD
screening would be a significant benefit to providers’ ability to detect and treat chlamydial
infection, and screening would have a positive impact on patients’ quality of life.
Untreated chlamydia and complications. Chlamydia trachomatis is the most common
STD in the United States. The actual number of chlamydial infections probably exceeds three
million annually because of undetected and untreated infections associated with asymptomatic
patients in most cases (Wiesenfeld, 2017). People between 15 and 24 years of age have the
highest reported rates of chlamydia, with these rates being higher in women than in men (CDC,
2015). Because of the significant impact of untreated chlamydial infection on reproductive
systems, many studies of patients who are infected with chlamydia have shown long-term
clinical sequelae of chlamydial infection in women including cervicitis, PID (Gottlieb, Xu, &
Brunham, 2013), and infertility (Morhason-Bello et al., 2014). Tamarelle et al. (2017) found that
the early screening and treatment for chlamydia in young women less than 25 years of age may
reduce the incidence of PID. A study by Morhason-Bello et al. (2015) showed a higher
proportion of chlamydial infection in women with infertility secondary to a tubal blockage
(20.5%). These studies consistently demonstrate the need for routine chlamydia screening
according to the CDC guidelines. The identification of a chlamydial infection can make a
difference in the quality of life experienced by infected women. It is important for all providers
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to comply with the CDC guidelines to prevent the serious impacts the infection can cause on
patients’ health and reproductive systems.
Lack of testing by providers. Chlamydia screening may be primarily a provider’s
decision in clinical settings. Pickett et al. (2018) found physicians to be inadequate in following
CDC guidelines for sexually active adolescents in pediatric EDs. The study sought to measure
physician adherence to the CDC guidelines for specimen collection and testing for chlamydia
with both symptomatic and asymptomatic female patients. A limitation to the study was that only
22.3% of potential participants responded to a mailed survey, and it is possible that not all
physicians were identified for inclusion in the survey. The study concluded that the CDC
guidelines for chlamydia testing for adolescents in the ED were not adhered by physicians.
Many providers appeared to lack recognition of the value of screening (Gift & Hogben, 2016).
In their studies, the authors discussed the significant need to implement chlamydia screening
according to the CDC guidelines. Despite the high prevalence of chlamydial infection in
asymptomatic patients, such screening is not routinely performed due to lack of awareness of the
CDC recommendations. The screening should be recognized as important in clinical practice but
is often not taken into account when providers determine which specific CDC guidelines apply to
a given patient.
Provider education. In a study by Operario et al. (2016), the authors identified that the
educational effect of chlamydia screening was significantly related to decreased chlamydial
reinfection. Providers could benefit from more education on the screening guidelines and from
knowing that appropriate populations can be screened in EDs for asymptomatic chlamydia,
which could lead to the diagnosis and treatment of many people before complications become a
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problem. In an RCT by McNulty et al. (2013), the authors found that receiving educational
interventions doubled providers’ chlamydia screening rates in practice over control practices.
Screening in the ED. The demand for ED care is growing for reasons including serious
medical problems, the number of patients who are uninsured or who use Medicaid (Gindi, Black,
& Cohen, 2016), and limited access to primary care (Coster, Turner, Bradbury, & Cantrell,
2017). Jenkins, Zahnd, Kovach, and Kissinger (2013) studied the prevalence of
Chlamydia/gonorrhea infection in ED patients by assessing the treatment and effect of ED
screening. Jenkins et al’s (2013) study was consistent with the other studies (Anaene et al.,
2016; Schneider, FitzGerald, Byczkowski, & Reed, 2016) in that they found that screening was
cost-effective for high-risk populations. Kreisel, Flagg, and Torrone (2017) conducted a study of
the trends in PID in ED visits. Their study demonstrated a decrease in the diagnosis of PID in
EDs during 2006–2013, but the number of females diagnosed in reproductive age remained high
in the ED. They also found that a certain vulnerable population such as low income, uninsured,
and Medicaid visited the ED because of PID. Therefore, the ED provides a window of
opportunity for chlamydia screening.
Increasing chlamydia screening. Increasing chlamydia screening is the best approach to
detect chlamydial infection, reduce transmission, and decrease the risk of PID. Several
interventions have been recommended to promote screening among the sexually active young
population, including improving providers’ knowledge (McKee et al., 2018; McNulty et al.,
2013), targeted outreach (Badarane et al., 2019), education for behavior change (Baird &
Merchant, 2014; McNulty et al., 2013; Phillipson, Gordon, Telenta, Magee, & Jansenn, 2015;
Tibbits et al., 2018), rapid testing (Natoli et al., 2014; Rivard et al., 2016), and preferred methods
of sampling such as self-collected specimens (Eaton et al., 2019; Lunny et al., 2015). Providers’

ASYMPTOMATIC CHLAMYDIA SCREENING

19

intention to provide chlamydia screening can be increased when their personal attitude of
screening is motivated by a positive behavioral change.
Conceptual Framework
The Iowa Model of Evidence-Based Practice was used for this evidence-based scholarly
project. The steps of the Iowa Model include identifying triggers, forming a team, reviewing the
literature, designing the practice change, implementing the practice change, and evaluating and
disseminating the results (Iowa Model Collaborative, 2017). Permission to use the Iowa Model
conceptual framework was granted on July 22, 2019, by the University of Iowa Department of
Nursing and a copy is provided in Appendix B.
Identifying a trigger. The trigger for this EBP project was the prevalence of chlamydia
in the Bronx community. Statistics show in that 2017, there were 1127.9 cases of chlamydia per
100,000 people in the Bronx, as compared to 939.5 cases in Manhattan and 358 cases in Long
Island (New York State Department of Health, 2017). Asymptomatic patients who meet the
CDC criteria for chlamydia screening were not being offered screening in the Bronx ED. The
project coordinator determined that screening asymptomatic eligible patients in the ED should
become a priority among ED providers in an attempt to help decrease the overall chlamydia rate
in the Bronx.
Forming a team. Team development for this scholarly project began with identification
of key stakeholders. A team was formed in the ED, which included the project coordinator, ED
physicians, and ED physician assistants (PAs) who ultimately participated in the EBP project.
The project team coordinator and the scholarly project chair worked collaboratively to ensure the
scholarly project utilized the most current evidence from the literature during development and
implementation.
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Reviewing the literature. The literature was collected and critically appraised by the
project coordinator. The project coordinator chose 29 research studies which analyzed the
strengths and limitations of screening for chlamydia. The evidence clearly showed that
screening was needed in asymptomatic high-risk populations. One of the keys to increasing
screening was educating providers on the CDC screening guidelines and obtaining their buy-in to
screen asymptomatic patients who presented to the ED with non-life-threatening conditions.
Designing the practice change. After the review of the literature, the project coordinator
decided to provide an educational intervention for the ED providers which concentrated on the
CDC recommendations for screening for chlamydia. This included the recommendation to
provide screening for all eligible asymptomatic patients, which was a change in practice for all
the ED providers. Prior to and after the educational intervention, a questionnaire was given to
the providers, and the results of the pre- and post-intervention questionnaires were compared to
measure the change in providers’ knowledge.
Implementing the practice change. After the ED provider educational intervention, the
practice change was initiated in the ED for a 60-day period. The project sought to increase the
providers’ knowledge of the CDC screening guidelines for chlamydia and increase the chlamydia
screening rates in asymptomatic patients who present to the ED for non-life-threatening
conditions.
Evaluating and disseminating the results. Results of the pre- and post-intervention
questionnaires were compared by the project coordinator. After the 60-day intervention, the
project coordinator compared the screening rate of the intervention with the 60 days prior to the
start of the intervention. The results of the project will be shared with the ED provider staff at a
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later time, and recommendations will be made for continued provider education and continued
integration of the intervention into the providers’ practice.
Summary
Educating providers and implementing the CDC chlamydia screening guidelines for
asymptomatic patients in the ED setting could decrease the overall rate of chlamydia in the
Bronx community. Recent literature points to providers’ lack of awareness of the CDC
guidelines for chlamydia screening and the providers’ lack of recognition of the value of
screening as two of the main reasons that patients are not being screened routinely. Furthermore,
the literature suggests a need for additional STD screening sites. Several articles focused on the
value of screening asymptomatic patients who meet the criteria for chlamydia screening when
they present to the ED for other non-emergent conditions.
The literature review supports the need to educate providers on the CDC guidelines for
chlamydia screening and to encourage screening of asymptomatic patients. The purpose of this
scholarly project was to increase ED providers’ awareness of the CDC guidelines about
chlamydia screening and increase screening rates in asymptomatic patients in the ED.
SECTION THREE: METHODOLOGY
Project Design
This evidence-based project utilized the Iowa Model for Evidence-Based Practice. Using
this model, an education intervention on the CDC screening guidelines for chlamydia was
conducted and evaluated with a pilot intervention. The data were interpreted via descriptive
statistics at the end of the project.
The purpose of this EBP project was to increase ED providers’ awareness of the CDC
guidelines about chlamydia screening and improve screening rates in asymptomatic patients in
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the ED. The project coordinator conducted a pretest for ED providers and then provided an
education intervention. Immediately following the education intervention, the providers were
given a posttest to determine if they had an increase in knowledge from the intervention. A
retrospective and prospective data analysis was conducted by the project coordinator, and the
results were compared to determine if there was an increase in screening of asymptomatic
patients per the CDC guidelines by the providers after the education intervention. This EBP
project used a prospective cohort design with a retrospective electronic medical record review to
examine the association between an evidence-based educational intervention and adherence to
guidelines.
Measurable Outcomes
After completion of the educational program on chlamydia screening guidelines, ED
providers were expected to show an increase in knowledge about chlamydia screening. This was
expected to be evidenced by an increase in the post-test score.
After completion of the chart audit, providers in an urban ED were expected to
demonstrate an increase in screening for asymptomatic chlamydia according to the CDC
guidelines. This was expected to be evidenced by an increase in the 60 days after the education
intervention compared to the previous 60 days screening.
Setting and Population
The evidence-based scholarly project was conducted in the ED of a Bronx hospital. The
ED is a Level III in the Bronx, NY. 29.7% of the population in the area lives below the poverty
line, and the majority are women aged 25-34 years. The largest ethnic group living in poverty is
Hispanic, followed by African American. In 2015, 54,416 adults made visits to this ED. A
letter of support from the organization is provided in Appendix F.
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During the pre-implementation phase of this scholarly project, the project coordinator
researched and compared the chlamydia rates for all New York City boroughs and the rates at the
Bronx ED. Chlamydia rates among females 15–24 years of age as well as among non-Hispanic
Black individuals were found to be high in the Bronx ED. The staff from the hospital who
participated in this project included all ED attending physicians, PAs, and one nurse
practitioner—the project coordinator. The providers were a variety of ages and were from a
multicultural population composed of Caucasian, Hispanic, Asian, and other ethnicities. They
provide care to any patient coming into the ED without regard to age, race, ethnicity, gender,
religion, or the ability to pay. The providers see a variety of medical conditions which can range
from abdominal pain, urinary tract infections, STIs, respiratory illnesses, cardiac problems, and
neurologic problems.
Ethical Considerations
The project team (project coordinator and project chair) completed research ethics
training to ensure protection of human subjects. The Collaborative Institutional Training
Initiative Certificate is provided in Appendix E. Further, the project was submitted to and
received approval from the Liberty University Institutional Review Board. A copy of the
approval letter is provided in Appendix G. After data were collected from patient’s charts, nonidentifying information about the patients was removed. The forms were shredded once the data
is extracted, and all the data collected will be kept for three years and then deleted. Furthermore,
no patient or provider information will be reported in any future presentations or publications.
No consent form was required for the participants. The data from participants will not be
released.
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Data Collection
The providers participated in a pretest and posttest after the education intervention to test
their knowledge and gather demographic information. A retrospective audit was conducted for
the 60 days prior to the provider education intervention to determine how many times
asymptomatic patients who met the screening criteria were actually screened for chlamydia in
the ED. In addition, a prospective audit was conducted for the 60 days following the provider
education intervention to determine the number of asymptomatic patients who were screened for
chlamydia in the ED according to the CDC guidelines.
Tools
A pre-education questionnaire (Appendix C) and post-education questionnaire (Appendix
D) were provided to all ED provider participants. Demographic information from the ED
providers was collected. A relevant tool was not found in the literature search; therefore, the preeducation questionnaire and post-questionnaire were modified from the study of Lorch et al.
(2013) to reflect the purpose of this scholarly project. Lorch et al. (2013) used a questionnaire to
evaluate if annual chlamydia screening for 16- to 29-year-old patients in general practice can
decrease chlamydial infection. The contents of the created questionnaires for this project
included ED providers’ demographics, chlamydia knowledge testing and management, and their
barriers to screening.
Intervention
The intervention for this evidence-based project was based on the CDC guidelines for
chlamydia screening. A PowerPoint presentation was used for the education intervention, which
was approximately 30 minutes. The intervention was conducted at the beginning of each shift
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for one week in the conference room of the ED. All ED providers were expected to attend the
presentation.
The number of chlamydia screenings for asymptomatic patients in the ED for 60 days
prior to the provider education intervention was obtained to determine how many times
asymptomatic patients who met the screening criteria were actually screened for chlamydia in
the ED. The pre-education questionnaire was provided to all ED provider participants to obtain a
measure of their knowledge to the CDC guidelines for chlamydia screening prior to the
education intervention. After the provider education intervention, the post-education
questionnaire was completed by the ED providers to assess knowledge gained from the
education intervention. The prospective audit was conducted for 60 days following the provider
education intervention to determine the number of asymptomatic patients who were screened for
chlamydia in the ED according to the CDC guidelines.
Timeline
The proposal was finished on July 31, 2019, and the defense of the project proposal was
presented on August 2, 2019, then approved by the Liberty University Institutional Review
Board on August 7, 2019. The project was conducted in the ED of a Bronx hospital and
completed on October 27, 2019. The statistical data was analyzed with SPSS on November 11,
2019. This project’s results and discussion were reviewed by chair on November 11, 2019. The
final defense will be scheduled after the chair approves the final scholarly project manuscript.
The doctoral project will be submitted to the Scholars Crossings after the final defense.
Feasibility Analysis
All ED participants were rewarded with a five-dollar gift voucher for the hospital
cafeteria after the post-education questionnaire.
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Data Analysis
Measurable outcome 1. The project coordinator reviewed, compared, and analyzed the
results of the pre-intervention questionnaire and the post-intervention questionnaire. The project
coordinator utilized SPSS to analyze the results. A t test was conducted to determine if there was
a statistically significant difference in the knowledge the providers gained from the educational
intervention on the CDC guidelines for chlamydia screening.
Measurable outcome 2. The project coordinator compared and analyzed the preintervention number of asymptomatic chlamydia screenings with the number of post-intervention
eligible asymptomatic chlamydia screenings. The project coordinator utilized Excel to compare
the results by determining a p value. The results did not show a statistically significant
difference between the pre-intervention and post-intervention screenings.
SECTION FOUR: RESULTS
The purpose of this scholarly project was to increase ED providers’ understanding of the
CDC guidelines for chlamydia screening and increase screening rates in asymptomatic patients
in the ED. The ED is a good place for STD screenings to identify undiagnosed infections,
especially among those with asymptomatic infections or at a higher risk due to their
demographic. This would be especially helpful in areas of the country where the rate of
chlamydia is higher, such as the Bronx. Testing of asymptomatic patients in the ED can increase
early identification of infections and facilitate treatment of patients and their partners.
Before the implementation of an ED provider educational intervention on the CDC
screening guidelines for chlamydia, a 60-day chart review was conducted from July 12, 2019,
until August 10, 2019. The chart review was performed to determine the number of
asymptomatic chlamydia screenings performed in the ED during that period. Prior to and after

ASYMPTOMATIC CHLAMYDIA SCREENING

27

the provider educational intervention, a questionnaire was used to determine the providers’ level
of knowledge on chlamydia screening. Sixty days following the ED provider educational
intervention, a repeat chart review was conducted for asymptomatic chlamydia screening.
A post-education intervention questionnaire (PEIQ) was also conducted with the ED
providers to uncover any issues the providers had with screening asymptomatic patients for
chlamydia (Appendix H).
Descriptive Statistics
Of the 27 Bronx ED participants, 12 were physicians, and 15 were PAs. One participant
declined to participate in the pre- and post-educational questionnaires. Demographic information
was obtained on age, gender, and years of ED experience. Demographic information can be
found in Table 1.
Table 1
Demographic Characteristics of ED Providers
Frequency Percent
Age
< 30
30–49
> 50
Gender
Male
Female
ED Experience
< 2 years
2–5 years
> 5 years
Note. N = 27.

7
15
5

25.9
55.6
18.5

9
18

33.3
66.7

5
8
14

18.5
29.6
51.9

Measurable Outcome 1
After completion of the educational program on chlamydia screening guidelines, it was
expected that the ED providers would show an increase in knowledge about chlamydia screening
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between the pre-intervention questionnaire and the post-intervention questionnaire. The
educational intervention, utilizing the pre-intervention and post-intervention questionnaire, was
conducted from August 11, 2019 until August 17, 2019. Questions on the pre- and postintervention questionnaire focused on asymptomatic chlamydia infections in women, the age
groups of women with the highest rates of infection, and the recommendation for annual
screenings for sexually active women under 25 years of age. The ED providers demonstrated a
significant increase in total correct answers on the post-intervention questionnaire. Question 1
asked which age group had the highest rate of chlamydia, Question 2 asked whether chlamydia is
asymptomatic in most women, and Question 3 asked whether annual screening is recommended
for sexually active females under age 25. The results of the questionnaires are presented in
Table 2
Correct Responses on the Pre-Educational Questionnaire and Post-Educational Questionnaire

Question 1
Question 2
Question 3

Pretest
n
%
18
66.7
22
81.5
19
70.4

Posttest
n
%
27 100.0
27 100.0
27 100.0

The pre-educational questionnaire scores and the post-educational questionnaire scores
were compared utilizing a t test. The results of the t test were p = 0.000, 0.000, and 0.001,
respectively. After the educational intervention, the ED providers’ knowledge about chlamydia
and the CDC screening guidelines had remarkably improved for each question. Measurable
outcome 1 was achieved since the post-intervention questionnaires indicated that 100% of the
ED providers were able to answer all three questions accurately.
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Table 3
Relationships Between the Pre- and Post-Educational Intervention Questionnaires
Mean

Std. Deviation

t

df

Sig. (2-tailed)

Pair 1 (Question 1) .444

.577

4.000

26

.000

Pair 2 (Question 2) .407

.501

4.228

26

.000

Pair 3 (Question 3) .444

.480

3.606

26

.001

Measurable Outcome 2
After completion of the educational intervention on chlamydia screening, it was expected
that providers would demonstrate an increase in the rate of screening of asymptomatic patients
according to the CDC screening guidelines. The number of asymptomatic screenings was
compared for the 60 days prior to the intervention and the 60 days after the intervention.
The pre-intervention data were collected from July 12, 2019, until August 10, 2019.
Chlamydia screening rate categories included high risk females older than 25 years, pregnant
females of all ages, females 24 years and younger, high-risk males, and patients who were
already screened in 2019. In addition, data was collected for patients with a history of chlamydia
infections in the category of high risk. No asymptomatic high-risk females 25 years of age and
older or asymptomatic high-risk males were screened.
Measurable outcome 2 was only partially met since the screening rate only increased
from 0.88% to 6.62% over a two-month period and the screenings only occurred in females 24
years of age and younger.
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Table 4
Total ED Patient Visits and Chlamydia Screening Categories

Female
Age 25+
High risk
ED screened
Already screened in 2019
Age < 25
Symptomatic
ED screened
Already screened in 2019
Asymptomatic
ED screened
Already screened in 2019
Male
High risk
ED screened
Already screened in 2019
Total

Pre-Intervention
Screening
n
rates (%)
2,470
2,273
239
128
53.60
52
21.80
197
84
44
52.30
15
17.90
114
1
0.88
24
21.10
2,117
230
75
32.60
13
5.65
4,587

Post-Intervention
Screening
n
rates (%)
2,816
2,603
237
121 51.10
48 20.30
213
77
55 71.40
15 19.50
136
9
6.62
34 25.00
2,202
146
50 34.2
6
4.11
5,018

Figure 1
Screening Rates

136
114

1

9

PRE-INTERVENTION POST-INTERVENTION
(N)
(N)
Total Numbers of Asymptomatic Female Younger than 25 Years Old
Total Numer of Screening
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Post-Intervention Survey and Results
Since the screening rates for asymptomatic chlamydia after the intervention were not
significantly improved, the project coordinator conducted a PEIQ to identify barriers to provider
screening in hopes of establishing effective strategies for encouraging the ED providers to
screen. The results of the educational intervention post-questionnaire showed the providers
knew the screening guidelines, and the PEIQ noted that all participants were aware of the CDC
chlamydia screening guidelines that recommend at least annual screening of asymptomatic
females younger than 25 years of age. Despite these factors, screening was found to be low in
the asymptomatic groups. The PEIQ survey focused on barriers to screening for the providers.
Twenty-three ED providers from the original group responded to the PEIQ. The
providers were asked about chlamydia screening practices and barriers to following the CDC
guidelines in the ED for asymptomatic patients. Of the 23 ED providers, four participants chose
not to test patients who were asymptomatic in the ED because they felt the ED was not the right
place to screen. Three participants thought that gynecology or primary care clinics were more
appropriate places for chlamydia screening. Fifteen participants stated that they would screen
asymptomatic patients for chlamydia according to the CDC guidelines.
After the PEIQ survey, the chlamydia screening rates were reevaluated for two weeks.
Five out of 36 eligible asymptomatic patients (12.9%) were screened in the Bronx ED during the
two-week period following the PEIQ.
SECTION FIVE: DISCUSSION
Implication for Practice
The goal of this scholarly project was to improve ED providers’ knowledge about
chlamydia and the CDC screening guidelines for chlamydia and increase screening rates in
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asymptomatic patients in the ED. Clearly, there was a significant difference in the providers’
knowledge level between the pre- and post-implementation questionnaires after the provider
education intervention. The providers also indicated on their questionnaires a willingness to
screen asymptomatic patients in the ED during an unrelated problem visit.
Although scores on all the post-intervention questionnaires showed 100% provider
awareness of the CDC guideline recommendations for chlamydia screening, chlamydia screening
rates in the Bronx ED were not significantly improved in the two-month period following the
intervention. The screening rate did increase from 0.88% to 6.62% over the two-month period.
All the screenings occurred in females 24 years of age and younger. This finding was consistent
with the findings of Keegan, Diedrich, and Peipert (2014), who reviewed literature on current
criteria and the rationale for Chlamydia trachomatis screening and suggested that health
practices were not following current screening recommendations satisfactorily.
Chlamydia screening of asymptomatic eligible women increased in the two weeks
following the PEIQ survey provided to the staff after the 60-day intervention period. The
purpose of this post-project survey was to identify ED provider barriers to screening
asymptomatic eligible patients in the ED for chlamydia and to elicit strategies to assist the ED
providers in screening their patients. The findings confirm that despite provider knowledge of
the screening guidelines for chlamydia, providers are reluctant to screen appropriate patients.
Barriers to screening included the fact that some providers felt that the ED was not the
appropriate place to screen asymptomatic patients and some providers felt that gynecology or
primary care clinics were better screening sites. Over half the providers surveyed reiterated that
they would screen asymptomatic patients in the ED according to the CDC guidelines. Clearly,
the ED providers will continue to screen symptomatic patients that present to the ED. The ED
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providers’ new knowledge about chlamydia screening guidelines and the fact that over half of
the providers are willing to screen asymptomatic patients is encouraging for future practice, and
it is hoped that more than half the eligible patients coming into the ED will be screened for
chlamydia in the future. This would help make a difference in the higher-than-average
chlamydia rates in the Bronx area.
Patient factors that pose a higher risk for chlamydial infection include gender, age, and
previous history of a chlamydia infection. This EBP project sought to increase chlamydia
screening in the eligible asymptomatic patient presenting to a Bronx ED. To improve screening
rates in the future, ED providers should have frequent educational updates on the CDC practices
guidelines for screening for chlamydia. In addition, provider perception was an identified barrier
to asymptomatic chlamydia screening the Bronx ED. Hopefully, with frequent provider
education and reminder sessions this barrier and misconception will be minimized.
Sustainability
The goal of sustainability for this EBP project was for the Bronx ED staff to continually
be aware of the CDC chlamydia screening guidelines, and if the opportunity arises in their
practice, to screen any eligible asymptomatic patients for chlamydia. The ED is an excellent
place to consider screening for eligible asymptomatic patients who meet the CDC screening
criteria. Many patients who use the services of the ED either do not have a primary health care
provider or are uninsured or low-income and have limited monetary resources. Screening
eligible patients in the ED would ultimately save the patient time and the community added
medical costs. Patients who are found positive would benefit from early treatment and may be
able to avoid the long-term health consequences of a chlamydial infection. Providers in the ED
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and their patients need to realize that screening for chlamydia is as easy as obtaining a urine
sample and only rarely would the patient need a pelvic examination.
This EBP project affords an opportunity for NPs to be designated as leaders in ensuring
that the ED providers keep current with the CDC recommendations for screening and continually
encourage the other ED providers to test their high-risk asymptomatic patients. The NPs could
also be responsible for coordinating and initiating the testing on all eligible patients who come
into the ED, regardless of the patient’s provider. This service could help sustain the practice that
was started by this scholarly project. In addition, the NPs could be responsible for educating the
patients 24 years of age and younger to help improve their knowledge of chlamydia and other
STIs.
Limitations
Several limitations to the normal ED practice occurred during the implementation phase
of this evidence-based project. During this time the hospital changed their computer system.
This caused many logistical problems for providers because they had to learn where to place
their orders, and many providers had a difficult time opening the old computer system to view
the patient’s previous medical history related to chlamydia infections.
Although all of the ED providers who attended the educational intervention scored 100%
on their post-educational questionnaire, there were some ED providers who expressed personal
biases against testing asymptomatic eligible patients in the ED. These biases included the
thought that screening should be done at a gynecology or primary care office and not in the ED
and the notion that the patient was not in the ED with that specific problem and should not be
tested.
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In addition, the pediatric ED saw many patients up to age 20 years during the project
period. Another limitation was that some ED providers were not available to participate in the
educational intervention but saw ED patients during the post-intervention phase. In the Bronx
area, there are other community hospitals for the patients to use, which may have decreased the
number of potential patients screened.
Dissemination Plan
This scholarly project will serve as an initiative for health care providers in the ED and
other clinics including primary care, gynecology, and pediatrics. The results of the project will
be disseminated at the quality improvement meetings in the Bronx ED, which will include the
specific data related to the result of the positive chlamydia test found during the post-educational
intervention period in an asymptomatic female patient 24 years of age. Additional dissemination
will occur through presentations at conferences, such as NP education, PA education, and
medical student education.
Summary
The goal of the project was to increase ED providers’ understanding of the CDC
guidelines for chlamydia screening, increase screening rates in asymptomatic patients in ED, and
provide early identification of chlamydial infections. Although the goal of this evidence-based
staff education intervention was to increase screening of asymptomatic eligible patients in the
ED, the rate of improvement was only from 0.88% pre-intervention to 6.62% during the 60-day
period after the education intervention. Despite the screening rates not being significantly
improved, the ED providers appreciated the opportunity to gain more knowledge and
understanding about the CDC guidelines for chlamydia and about the high prevalence of
chlamydia in the Bronx. Through provider continuing education and reminder sessions, the
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practice of screening asymptomatic eligible patients in the ED for chlamydia should become
routine as providers see eligible asymptomatic patients for other non-life-threatening problems.
In turn, this will ultimately help decrease the number of cases of chlamydia seen in the Bronx,
New York.

ASYMPTOMATIC CHLAMYDIA SCREENING

37

References
Anaene, M., Soyemi, K., & Caskey, R. (2016). Factors associated with the over-treatment and
under-treatment of gonorrhea and chlamydia in adolescents presenting to a public
hospital emergency department. International Journal of Infectious Diseases, 53, 34–38.
doi:10.1016/j.ijid.2016.10.009
Badarane, D., Knox, J., Camacho, A., Magill, M. K., Van Hala, S., & Jones, J. L. (2019).
Increasing chlamydia testing rates via targeted outreach. PRiMER, 3(17).
doi:10.22454/PRiMER.2019.669190
Baird, J., & Merchant, R. C. (2014). A randomized controlled trial of the effects of a brief
intervention to increase chlamydia and gonorrhea testing uptake among young adult
female emergency department patients. Academic Emergency Medicine, 21(12), 1512–
1520. doi:10.1111/acem.12539
Carlson, A. D. P., Tschann, M., Santibenchakul, S., Hurwitz, E. L., & Salcedo, J. (2017).
Physician adherence to sexually transmitted infection screening guidelines in an
OB/GYN teaching clinic in Hawai’i. Hawai’i Journal of Medicine and Public Health,
76(11), 299–304. doi:10.1177/1524839918769592.
Centers for Disease Control and Prevention. (2015). 2015 Sexually transmitted diseases
treatment guidelines. Retrieved from https://www.cdc.gov/std/tg2015/screeningrecommendations.htm
Centers for Disease Control and Prevention. (2016). STDs during pregnancy – CDC fact sheet
(detailed). Retrieved from https://www.cdc.gov/std/pregnancy/stdfact-pregnancydetailed.htm

ASYMPTOMATIC CHLAMYDIA SCREENING

38

Centers for Disease Control and Prevention. (2017). Sexually transmitted disease surveillance
2017. Retrieved from https://www.cdc.gov/std/stats17/default.htm
Coster, J. E., Turner, J. K., Bradbury, D., & Cantrell, A. (2017). Why do people choose
emergency and urgent care services? A rapid review utilizing a systematic literature
search and narrative synthesis. Academic Emergency Medicine, 24(9), 1137–1149.
doi:10.1111/acem.13220
Eaton, S., Biggerstaff, D., Petrou, S., Osipenko, L., Gibbs, J., Estcourt, C. S., . . . Szczepura, A.
(2019). Young people’s preferences for the use of emerging technologies for
asymptomatic regular chlamydia testing and management: A discrete choice experiment
in England. BMJ Open, 9(1), e023663. doi:10.1136/bmjopen-2018-023663
Ghanem, K. G., & Tuddenham, S. (2017). Screening for sexually transmitted infections.
Retrieved from https://www.uptodate.com/contents/screening-for-sexually-transmittedinfections
Gift, T. L., & Hogben, M. (2016). Emergency department sexually transmitted disease and
human immunodeficiency virus screening: Findings from a national survey. Academic
Emergency Medicine, 13(9), 993–996. doi:10.1197/j.aem.2006.04.017
Gindi, R. M., Black, L. I., & Cohen, R. A. (2016). Reasons for emergency room use among U.S.
adults aged 18–64: National health interview survey, 2013 and 2014 (National Health
Statistics Report No. 90). Retrieved from National Center for Health Statistics website:
https://www.cdc.gov/nchs/data/nhsr/nhsr090.pdf
Gottlieb, S. L., Xu, F., & Brunham, R. C. (2013). Screening and treating Chlamydia trachomatis
genital infection to prevent pelvic inflammatory disease: Interpretation of findings from

ASYMPTOMATIC CHLAMYDIA SCREENING

39

randomized controlled trials. Sexually Transmitted Diseases, 40(2), 97–102.
doi:10.1097/OLQ.0b013e31827bd637
Goyal, M. K., Witt, R., Hayes, K. L., Zaoutis, T. E., & Gerber, J. S. (2014). Clinician adherence
to recommendations for screening of adolescents for sexual activity and sexually
transmitted infection/human immunodeficiency virus. The Journal of Pediatrics, 165(2),
343–347. doi:10.1016/j.jpeds.2014.04.009
Iowa Model Collaborative. (2017). Iowa model of evidence-based practice: Revisions and
validation. Worldviews on Evidence-Based Nursing, 14(3), 175-182.
doi:10.1111/wvn.12223
Jenkins, W. D., Zahnd, W., Kovach, R., & Kissinger, P. (2013). Chlamydia and gonorrhea
screening in United States emergency departments. The Journal of Emergency Medicine,
44(2), 558–567. doi:10.1016/j.jemermed.2012.08.022
Keegan, M. B., Diedrich, J. T., & Peipert, J. F. (2014). Chlamydia trachomatis infection:
Screening and management. Journal of Clinical Outcomes Management, 21(1), 30–38.
Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279217
Kreisel, K., Flagg, E. W., & Torrone, E. (2017). Trends in pelvic inflammatory disease
emergency department visits, United States, 2006–2013. American Journal of Obstetrics
and Gynecology, 218(1), 117.e1–117.e10. doi:10.1016/j.ajog.2017.10.010
Lorch, R., Hocking, J., Temple-Smith, M., Law, M., Yeung A., Wood, A., . . . Guy, R. (2013).
The chlamydia knowledge, awareness and testing practices of Australian general
practitioners and practice nurses: Survey findings from the Australian chlamydia control
effectiveness pilot (ACCEPt). BMC Family Practice, 14(169). doi: 10.1186/1471-229614-169

ASYMPTOMATIC CHLAMYDIA SCREENING

40

Lunny, C., Taylor, D., Hoang, L., Wong, T., Gilbert, M., Lester, R., . . . Ogilvie, G. (2015). Selfcollected versus clinician-collected sampling for chlamydia and gonorrhea screening: A
systemic review and meta-analysis. PLoS One, 10(7), e0132776.
doi:10.1371/journal.pone.0132776
McKee, D. M., Alderman, E., York, D. V., Blank, A. E, Briggs, R. D., Hoidal, K. E. S., . . .
Racine, A. D. (2018). A learning collaborative approach to improve primary care STI
screening. Clinical Pediatrics, 57(8), 895–903. doi:10.1177/0009922817733702
McNulty, C. A. M., Hogan, A. H., Ricketts, E. J., Wallace, L., Loiver, I., Campbell, R., . . .
Charlett, A. (2013). Increasing chlamydia screening tests in general practice: A modified
Zelen prospective cluster randomized controlled trial evaluating a complex intervention
based on the theory of planned behavior. Health Services Research, 90(3), 188–194.
doi:10.1136/sextrans-2013-051029
Melnyk, B. M., & Fineout-Overholt, E. (2005). Making the case for evidence-based practice. In
B. Melnyk & E. Fineout-Overholt (Eds.), Evidence-based practice in nursing &
healthcare: A guide to best practice (pp. 3-24). Philadelphia, PA: Wolters Kluwer Health.
Menon, S., Timms, P., Allan, J. A., Alexander, K., Rombauts, L., Horner, P., . . . Huston, W. M.
(2015). Human and pathogen factors associated with Chlamydia trachomatis-related
infertility in women. Clinical Microbiology Reviews, 28(4). 969–985.
doi:10.1128/CMR.000035-15
Morhason-Bello, I. O., Ojengbede, O. A., Oladokun, A., Adedokun, B. O., Ajayi, A., Adeyanju,
A. A., . . . Kareem, O. I. (2014). The prevalence and outcome of asymptomatic
chlamydial infection screening among infertile women attending gynecological clinic in

ASYMPTOMATIC CHLAMYDIA SCREENING

41

Ibadan, South West Nigeria. Annals of Medical and Health Science Research, 4(2), 253–
257. doi:10.4103/2141-9248.129057
Natoli, L., Maher, L., Shephard, M., Hengel, B., Tangey, A., Badman, S. G., . . . Guy, R. J.
(2014). Point-of-care testing for chlamydia and gonorrhea: Implications for clinical
practice. PloS One, 9(6), e100518. doi:10.1371/journal.pone.0100518
New York State Department of Health. (2017). Sexually transmitted infections surveillance
report: New York State. Retrieved from
https://www.health.ny.gov/statistics/diseases/communicable/std/docs/sti_surveillance_rep
ort_2017.pdf
Operario, D., Wang, D., Zaller, N. D., Yang, M. F., Blaney, K., Cheng, K., . . . Coates, T. J.
(2016). Effect of a knowledge-based and skills-based programme for physicians on risk
of sexually transmitted reinfections among high-risk patients in China: A cluster
randomized trial. Lancet Global Health, 4(1), e29–e36. doi:10.1016/S2214109X(15)00249-1
Owusu-Edusei, K., Chesson, H. W., Gift, T. L., Tao, G., Mahajan, R., Ocfemia, M. C., & Kent,
C. K. (2013). The estimated direct medical cost of selected sexually transmitted
infections in the United States, 2008. Sexual Transmitted Disease, 40(3), 197–201.
doi:10.1097/OLQ.0b013e318285c6d2
Phillipson, L., Gordon., R., Telenta, J., Magee, C., & Janssen, M. (2015). A review of current
practices to increase chlamydia screening in the community – A consumer‐centered
social marketing perspective. Health Expect, 19(1), 5–25. doi:10.1111/hex.12337
Pickett, M. L., Melzer-Lange, M. D., Miller. M. K., Menson, S., Vistocky, A. M., & Drendel, A.
L. (2018). Physician adherence to CDC guidelines for sexually active adolescents in the

ASYMPTOMATIC CHLAMYDIA SCREENING

42

pediatric emergency setting. Pediatric Emergency Care, 34(11), 767–773.
doi:10.1097/PEC.0000000000000873
Redgrove, K. A., & McLaughlin, E. A. (2014). The role of the immune response in Chlamydia
trachomatis infection of the male genital tract: A double-edged sword. Frontiers in
Immunology, 5(534). doi:10.3389/fimmu.2014.00534
Rivard, K. R., Dumkow, L. E., Draper, H. M., Brandt, L. K. L., Whalen, D. W., & Egwuatu, N.
E. (2016). Impact of rapid diagnostic testing for chlamydia and gonorrhea on appropriate
antimicrobial utilization in the emergency department. Diagnostic Microbiology and
Infectious Disease, 87(2), 175–179. doi:10.1016/j.diagmicrobio.2016.10.019
Schneider, K., FitzGerald, M., Byczkowski, T., & Reed J. (2016). Screening for asymptomatic
gonorrhea and chlamydia in the pediatric emergency department. Sexually Transmitted
Disease, 43(4), 209–215. doi:10.1097/OLQ.0000000000000424
Tamarelle, J., Thiébaut, A. C. M., Sabin, B., Bébéar, C., Judlin, P., Fauconnier, A., . . .
Delarocque-Astagneau, E. (2017). Early screening for chlamydia in young women for
primary prevention of pelvic inflammatory disease (i-Predict): Study protocol for a
randomized controlled trial. Europe PMC, 18(1), 534. doi:10.1186/s13063-017-2211-1
Tibbits, M., Maloney, S., Ndashe, T., Grimm, B., Johansson, P., & Siahpush, M. (2018). Impact
of the community-wide adolescent health project on sexually transmitted infection testing
in Omaha, Nebraska. American Journal of Public Health, 108(6), 782–784.
doi:10.2105/AJPH.2018.304391
Wiesenfeld, H. C. (2017). Screening for Chlamydia trachomatis infections in women. The New
England Journal of Medicine, 376, 765–772. doi:10.1056/NEJMcp1412935

ASYMPTOMATIC CHLAMYDIA SCREENING

43
Appendix A
Evidence Table

Name: Mikyung Kim
Clinical Question: In healthcare providers located in an urban ED, does an educational intervention focusing on the CDC
guidelines for screening for chlamydia, as compared to current knowledge on screening, lead to increased overall knowledge and
increased screening rates for chlamydia in asymptomatic patients in the ED?
Author (year)

Study
Purpose/
Objective(s)

Anaene, M., Soyemi, K.,
& Caskey, R. (2016).
Factors associated with
the over-treatment and
under-treatment of
gonorrhea and chlamydia
in adolescents presenting
to a public hospital
emergency department.
International Journal of
Infectious Diseases, 53,
34-38.
doi:10.1016/j.ijid.2016.1
0.009

To evaluate
the rates of
STDs, the
rates of overtreatment
(OT) and
undertreatment
(UT) of
STDs, and the
factors related
to OT and
UT.

Design,
Sampling
Method, &
Subjects
797 patients
aged 13-24
screened for
CT/GC in
the
emergency
department
(ED) of
John H.
Stronger
Hospital in
Cook
county

LOE

Intervention &
Outcomes

Results

Study
Strengths &
Limitations

Level V

A nonexperimental
systemic,
retrospective
chart review

21.6% showed
positive of
CT/GC. 21.6%
was OT and
43.4% was UT.
Patients
complaining
with sexually
transmitted
infections
exposure or GU
symptoms were
more likely to
be OT.

A single
public
hospital; the
results may
not
generalize to
all hospitals.
No causeand-effect
relationships

Would Use as
Evidence to
Support a
Change?
Yes, the finding
was well
answered to the
purpose of the
study. The GC/CT
rapid testing
would decrease
the OT/UT.
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Badarane, D., Knox, J.,
Camacho, A., Magill, M.
K., Van Hala, S., &
Jones, J. L. (2019).
Increasing chlamydia
testing rates via targeted
outreach. PRiMER,3(17).
doi:10.22454/PRiMER.2
019.669190
Carlson, A. D.P.,
Tschann, M.,
Santibenchakul, S.,
Hurwitz, E. L., &
Salcedo, J. (2017).
Physician adherence to
sexually transmitted
infection screening
guidelines in an
OB/GYN teaching clinic
in Hawai’i. Hawai’i
Journal of Medicine and
Public Health, 76(11),
299-304.
doi:10.1177/1524839918
769592

Centers for Disease
Control and Prevention.
(2015). 2015 Sexually
transmitted diseases
treatment guidelines.

To assess
effectiveness
chlamydia
screening QI
interventions
(patient
targeted
outreach)
To evaluate
physicians
adherence to
STD
screening
guidelines and
to determine
demographic
factors such
as age group,
race,
insurance
type, and visit
type related to
STD
recommendati
ons among
women 14–25
years old
To determine
the CDC
recommendati
ons for
screening for
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Average
60.6 women
per month
during the
2016-2017
and 60.2
women
during
2017-2018
446 patients

Level IV

Prospective
cohort study

Outreach efforts Small
increase
sample,
chlamydia
single clinic
screening rates

Level V

A retrospective
chart review

Demographic
Single
factors were
outpatient
influenced with GYN clinic
a significant
gap in physician
adherence to
STD screening
guidelines
(71.0% received
screening
recommendatio
ns).

Systematic
literature
review
using an
extensive

Level I

High quality
prospective
cohort study
with systematic
review

The chlamydia
is the most
frequently
reported
infectious

The
recommenda
tions might
be modified
by the

Yes, successful
intervention to
target population
can improve
chlamydia
screening and the
QI project can be
replicated to other
clinical settings.
Yes, this study
strengthened the
importance of
physician
recommendations.

Yes. This CDC
recommendations
provide validity
and reliability of
the evidence
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Retrieved from
https://www.cdc.gov/std/
tg2015/screeningrecommendations.htm

chlamydial
infection and
the supporting
scientific
evidence

MEDLINE
database

diseases in the
U.S. and
prevalence is
highest in
persons aged
less than 25
years.

Natoli, L., Maher, L.,
Shephard, M., Hengel,
B., Tangey, A., Badman,
S. G., . . . Guy, R. J.
(2014). Point-of-care
testing for chlamydia and
gonorrhea: Implications
for clinical practice. PloS
One, 9(6), e100518.
doi;10.1371/journal.pone
.0100518

To assess
whether
routine pointof –care
(POC) testing
for CT/GC is
effective in
remote
settings.

Purposive
sampling 18
participants

Level VII Expert opinion

Identified the
POC testing
needs
management
pathways to
improve STDs
care.

Owusu-Edusei, K.,
Chesson, H. W., Gift, T.
L., Tao, G., Mahajan, R.,
Ocfemia, M. C., & Kent,
C. K. (2013). The
estimated direct medical
cost of selected sexually
transmitted infections in
the United States, 2008.
Sexual Transmitted
Disease, 40(3), 197-201.
doi:10.1097/OLQ.0b013
e318285c6d2.

To estimate
the direct
medical cost
to sexually
transmitted
infections.

No
applicable

Level V

In 2008, 516.7
million dollars
costed for
chlamydial
infection.

Decretive
retrospective

certain
population,
prevalence,
and
providers’
perspective
in the
community
Small
sample size,
no
experiment
study

utilization in
chlamydia
screening.

No
intervention.

Yes, the findings
suggested the
need of chlamydia
prevention and
management.
Currently the total
costs for the
chlamydia would
be even greater
because of the
growing
chlamydia rates.

Yes, the POC
testing would
detect chlamydia
for those
asymptomatic
people and
provide better
STDs care.
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(2016). Reasons for
emergency room use
among U.S. adults aged
18–64: National health
interview survey, 2013
and 2014. National
Health Statistics Reports,
90. Retrieved from
https://www.cdc.gov/nch
s/data/nhsr/nhsr090.pdf

To examine
the factors
associated
with patient
visit to the
ED.

National
health
interview
survey from
the 2013
and 2014;
26,825
sample
adults aged
18-64 in
2013 and
28,053 aged
10-64 in
2014.

Level V

Descriptive
retrospective
review

Coster, J. E., Turner, J.
K., Bradbury, D., &
Cantrell, A. (2017). Why
do people choose
emergency and urgent
care services? A rapid
review utilizing a
systematic literature
search and narrative
synthesis. Academic
Emergency Medicine,
24(9), 1137-1149.
doi:10.1111/acem.13220

To identify
patients’
reasons to
visit urgent
and
emergency
care

38 studies
from
literature
review
between
1995 and
2016.

Level III

Systemic
review with
meta-analysis

The choice of
ED visit for
adults was
affected by their
insurance type.
Uninsured
adults visited
EDs more than
private
coverage adults.
About 79.7% of
adults visited
ED because of
lack of access to
other providers.
Identified
reasons
including
unavailable
primary clinic,
perceived
urgency,
significant
others’
recommendatio
n, convenience,
and perceived
need for
emergency
services.

Possible
interviewees
’ recall bias
of the type
of illness and
insurance.

Yes, the finding
are consistent to
our ED
population. The
data will be a
good resource to
support the
project.

Rapid
review. No
suggestion
for change

Yes, this study
supports that most
ED patients tend
to consider EDs
are more
convenient and
accessible for
those with low
socioeconomic
status.
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department sexually
transmitted disease and
human
immunodeficiency virus
screening: Findings from
a national survey.
Academic Emergency
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996.
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4.017

To analyze
the screen
rates of STD
and human
immunodefici
ency virus by
ED providers
compared
with other
settings’
providers
(primary
clinics,
hospital
ambulatory
clinics, or
other)

3,838
survey
respondents

Level VI

Descriptive
study

ED providers
Small
were less
sample size.
screening for
the STDs and
human
immunodeficien
cy virus

Yes, the findings
can be compared
to this project.

Eaton, S., Biggerstaff,
D., Petrou, S., Osipenko,
L., Gibbs, J., Estcourt, C.
S., . . . Szczepura, A.
(2019). Young people’s
preferences for the use of
emerging technologies
for asymptomatic regular
chlamydia testing and
management: a discrete
choice experiment in
England. BMJ Open,
9(1):e023663.
doi:10.1136/bmjopen2018-023663

To assess the
preference
test options
and treatment
of
asymptomatic
chlamydia

1230 young
people aged
16–24 years

Level IV

mixed methods
design

The strongest
preference
factors were
chlamydia test
accuracy and
followed by
time to result.
The highest
preference for
remote
chlamydia
testing options
are self-testing,
self-sampling

Yes, the findings
would be a good
resource to apply
to increase
screening
according to
people’s
preference.

This study
used an
online panel
that could
limit
generalizabil
ity because
only 1,230
young
people
responded to
questionnair
es.
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controlled trial of the
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intervention to increase
chlamydia and gonorrhea
testing uptake among
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and postal
testing.
48% in the
brief
intervention
group accepted
testing while
36% in the
control group
accepted
testing. The
chlamydia
positivity rate
was 7%.

To evaluate
the effect of a
brief
educational
and
counseling
intervention
on increasing
the STD
testing among
asymptomatic
young female
ED patients.
To analyze
randomized
controlled
trial findings
(secondary
data analysis)

171 women,
a
convenience
sample of
aged 18-35
years in two
EDs

Level I
RCT

A randomized
controlled trial.
Offered a brief
educational and
counselling
intervention

Small
sample, a
convenience
sample (not
randomly
selected
from the ED
population)

Six
randomized
trial
research
review

Level I

Systemic
review with
RCTs and metaanalysis

Chlamydia
screening and
treatment is a
positive
intervention to
reduce the risk
of PID

Uncertain of
timing of
PID relative
to screening,

Yes, most
women who are
infected with
chlamydia appear
asymptomatic.
Screening is an
important
strategy in
preventing the
sequelae of
untreated
chlamydial
infection.
Yes, screening
strategy would be
more enhanced to
prevent PID.

To examine
physician
adherence to
guidelines for

1000
randomly
selected 13to 19-year-

Level
IV

Retrospective,
cross-sectional
study

Pediatric
primary care
physicians
infrequently

No
control/inter
vention
group

Yes, these
findings support
physicians’
nonadherence to
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immunodeficiency virus.
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documentatio
n of sexual
history and
screening for
STD.
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old routine
well visits

document
sexual histories
and practice
STD screening

CDC guideline
for chlamydia
screening.

To evaluate
42 articles
the prevalence from 1995
of CT/GC
to 2010
infection in
ED patients
assessing the
treatment and
effect of ED
screening

Level III

Systemic
review with
meat-analysis

Posotive rates
of STDs is high
and are in the
high-risk
populations in
ED.

Exclusion of
non-English
-speaking
nations

To assess the
prevalence of
PID in ED

Level
III

Systemic
review with
meta-analysis

A percentage of
ED visits with
low income, no
insurance,
public health
because of PID
increased
during 2006–
2013 while the
episode of ED

No single
test or
laboratorybased
diagnosis,
but mostly
rely on
clinical signs
and
symptoms.

Data from
HCUP
NEDS;
during
2006–2013,
25.7 million
to 31.0
million
annual ED

Yes, educating
ED providers on
the topics of
chlamydia
epidemiology,
sample collection,
and analysis will
enable them to
address the risks
in their presenting
populations.
Yes, the lower
incidence of the
PID would have
related to increase
STD screening
effort.

ASYMPTOMATIC CHLAMYDIA SCREENING
doi:10.1016/j.ajog.2017.
10.010

Lunny, C., Taylor, D.,
Hoang, L., Wong, T.,
Gilbert, M., Lester, R., . .
. Ogilvie, G. (2015).
Self-collected versus
clinician-collected
sampling for chlamydia
and gonorrhea screening:
A systemic review and
meta-analysis. PLoS
One, 10(7):e0132776.
doi:10.1371/journal.pone
.0132776

Menon, S., Timms, P.,
Allan, J. A., Alexander,
K., Rombauts, L.,
Horner, P., . . . Huston,
W. M. (2015). Human
and pathogen factors
associated with
Chlamydia trachomatisrelated infertility in

50

visits from
24–30 states

To compare
self-collected
vaginal, urine,
pharyngeal
and rectal
samples at
home-based
to providers
collected
cervical,
urethral,
pharyngeal
and rectal
sampling
techniques at
clinical
settings
To analyze
human-based
evidence that
relates
chlamydia
with
reproductive
pathologies in
women

visit with PID
in females aged
15-44 years
decreased.

The significant
validity of
vaginal selfcollected swabs
compared to
swabs collected
by providers
and of urine
samples for
men at home.

As a result,
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be diagnosed
by
physicians’
subjective
practice.
No studies
included
internetbased selfcollection, in
rural area,
and few
studies
addressed
gonorrhea
selfcollection.

21 studies
based on
over 6100
paired
samples

Level
III

Systemic
review with
meta-analysis

Not
applicable

Level
I

Systemic
Described that
Not
literature review chlamydia
applicable
with RCTs
genotypes,
immune
responses that
sexual behavior,
coinfections,
and repeat
infections are

Yes, selfscreening would
be increasing the
rates of STDs
screening.

Yes, this literature
is a
comprehensive
review and would
encourage to
screening for at
risk asymptomatic
women. Supports
that fact PID may
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resulted in
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and chlamydia
infection causes
PID.
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screening for
sexual activity
and sexually
transmitted
infections

11 Bronx
Level II
Ongoing
Pediatric
Screening
(BOPS) and
participating
sites and 10
nonparticipating
sites.

Well-designed
control trials
without
randomization

Screening at
non–health care
maintenance
visits improved
more at BOPS
sites

Less strong
in internal
validity
because of
nonrandomized

Yes, this research
was conducted in
the Bronx, New
York. The results
would be the best
resources to this
student’s project.

To assess
effectiveness
chlamydia
screening
intervention
to general
practitioners
in England

76
intervention
and 81
control
practices

Randomized
controlled trial

Doubled
chlamydia
screening rates

Many
components
of the theory
of planned
behavior
(TPB)
interventions
might not
fully utilized
as education
interventions
for a
research. So
the outcomes
of another

Yes, consistent to
the benefit of
intervention to
chlamydia
screening

Level I

ASYMPTOMATIC CHLAMYDIA SCREENING

52

doi:10.1136/sextrans2013-051029.

Morhason-Bello, I. O.,
Ojengbede, O. A.,
Oladokun, A.,
Adedokun, B. O., Ajayi,
A., Adeyanju, A. A., . . .
Kareem, O. I. (2014).
The prevalence and
outcome of
asymptomatic chlamydial
infection screening
among infertile women
attending gynecological
clinic in Ibadan, South
West Nigeria. Annals of
Medical and Health
Science Research, 4(2),
253-257.
doi:10.4103/21419248.129057
Operario, D., Wang, D.,
Zaller, N. D., Yang, M.
F., Blaney, K., Cheng,
K., . . . Coates, T.J.
(2016). Effect of a
knowledge-based and
skills-based programme
for physicians on risk of
sexually transmitted

To evaluate
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the
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relationship
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chlamydial
infection and
infertile
women and
hysterosalping
ogram (HSG).

Level V

Retrospective
study

To evaluate a
knowledgebased and
skills-based
programme
for physicians
in China to
reduce

Level I

Clustered
Significant
randomized trial decrease of
chlamydia
reinfection rates
in the
intervention
group

249
physicians
(121
physicians
in the
intervention
group and
128 in the

Asymptomatic
chlamydial
infection is
common among
infertile women
and it
significantly
predict HSG
blockage.

similar
research
with TPB
would be
different.
Small
sample, short
periods of
infertile

Participants
within a
cluster might
be treated
similarly and
have similar
outcomes.
As a result,
the

Yes, this study
can be a
significant
evidence to treat
chlamydia to
prevent infertility.

Yes, the
educational
intervention to
physicians would
increase the
screening rate.
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control
group)
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effectiveness
chlamydia
screening
interventions
in young
adults less
than 30 years
old in
community
setting (Social
marketing
benchmark
criteria)

30 full-text
literature
review
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reliability
and validity
would have
been
affected.

Level III

Systemic
review with
meta-analysis

Social
Quality of
marketing
evidence
benchmark
was low
intervention (a
consumercentered
approach to
behavior
change)
resulted positive
outcomes
(increase
screening rate)

Yes, benchmark
criteria would be
a good resources
to utilize for
implementation of
intervention
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the impact of
chlamydia
and gonorrhea
rapid
diagnostic
testing (RDT)
in an urban
emergency
department
(ED) on
treatment
appropriatene
ss, time to
notification,
and cost.

The
traditional
testing
group and
the RDT
group
consisted of
200
consecutive
patients
from
December
2013–
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2014.

Level III

A quasi‐
experimental
study.

The RDT group
had a
significant
increase in
treatment, faster
notification for
results, and cost
savings.

Conducted
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setting, small
sample size
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patients and
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antibiotics for
negative patients.
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Chlamydia
knowledge for
increasing
screening.

General
practitioners
and
practical
nurses.

Level II

A randomized
control trial.

Gaps between
chlamydia
knowledge and
practice.

Difference
chlamydia
knowledge
and interest
between the
general
practitioners
and practical
nurses.
General
practitioners
were
recruited
while
practical

Yes, the
questionnaire
used by this study
would be
resourceful to
design a modified
questionnaire for
the project.

ASYMPTOMATIC CHLAMYDIA SCREENING

55

10.1186/1471-2296-14169

nurses were
randomized
selected at
the clinic
that
chlamydia
screening is
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knowledge of
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partner
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(EPT).
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Level IV
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Internet-based
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Keegan, M. B., Diedrich,
J. T., & Peipert, J. F.
(2014). Chlamydia
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46.0% less than
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Screening
for chlamydia
for women age
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members of
the AAP
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enhance the
current guidelines
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screening
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PID over
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early
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active
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under 25
years old
enrolled at
five
universities
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positive results.
Control group’s
vaginal home
swab samples
will be delayed

25 and younger
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women of 26
and older at
increased risk
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the early
treatment of
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avoiding
sequelae of
untreated
chlamydial
infection such
as PID, ectopic
pregnancy, and
reducing health
care costs.
The study
protocol will be
implanted with
the results of
the incidence of
first PID over
24 months in
the
experimental
group’s and in
the control
group’s
measurement of
duration of
chlamydia

chlamydia
screening

should be
practiced in EDs
as CDC
guidelines

Ethical
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control
group’s
deferred
chlamydia
analysis of
collected
vaginal
samples at
first. No
actual results
found in the
study.
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the
effectiveness
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testing) to
STD
screening rate

Young
Level IV
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(64%), and
almost half
were
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24 years of
age (46%),
ethnicity
(Hispanic,
34%,;
White, 31%;
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American,
25%; and
other
racial/ethnic
groups,
10%).
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until the end of
the study
period.

infection at 6 or
12 or over 18
months.

Prospective
study
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increase STD
screening rates
during the
phase 2 (free
STI testing).

The
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primary
analysis
completion
date is
October
2021.
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through media
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(68% of
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Cross sectional
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study

40 participants
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Yes, the findings
justify the CDC
recommendations.

Redgrove, K. A., &
McLaughlin, E. A.
(2014). The role of the
immune response in
Chlamydia Trachomatis
infection of the male
genital tract: A doubleedged sword. Frontiers
in Immunology, 5(534).
doi:10.3389/fimmu.2014.
00534

To examine
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Appendix C
Pre-Education Questionnaire
A. Characteristic
Sex

Female

Age group

<30 years
30-49 years
>50 years

Years experienced in the
ED

<2 years
2-5 years
>5 years

B. Statistics
Which borough has the
highest number of
chlamydia in New York

Bronx
Brooklyn
Manhattan
Queens
Staten Island

Which age groups have
the highest rates of
chlamydia infection in
women

Aged 15-19 years
Aged 20-24 years
>25 years

Most chlamydia
infections are
asymptomatic in women

Yes
No

Male

ASYMPTOMATIC CHLAMYDIA SCREENING
C. According to the CDC guidelines 2015, chlamydia
Annual screening is
recommended to sexually
active women under 25
years of age
Annual screening is
recommended to
sexually active women
aged 25 years old if an
increased risk
Retest approximately 3
months after treatment

Yes
No
Yes
No

Yes
No

Treatment of chlamydia
with a single I g dose of
azithromycin or
doxycycline 100 mg
twice a day
Chlamydia alternative
regimens are
Erythromycin,
Levofloxacin, or
Ofloxacin

Yes
No
Yes
No
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Post-Education Questionnaire
A. Statistics
Which borough has the
highest number of
chlamydia in New York

Bronx
Brooklyn
Manhattan
Queens
Staten Island

Which age groups have
the highest rates of
chlamydia infection in
women

Aged 15-19 years
Aged 20-24 years
>25 years

Most chlamydia
infections are
asymptomatic in women

Yes
No

B. According to the CDC guidelines 2015, chlamydia
Screening is
recommended to sexually
active women under 25
years of age
Screening is
recommended to
sexually active women
aged 25 years old if an
increased risk
Retest approximately 3
months after treatment

Yes
No
Yes
No

Yes
No
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Treatment of chlamydia
with a single I g dose of
azithromycin or
doxycycline 100 mg
twice a day
Chlamydia alternative
regimens are
Erythromycin,
Levofloxacin, or
Ofloxacin

Yes
No
Yes
No
C. Possible barriers

Over treating
Time constraints
Religion/ethnicity
Did not know the CDC
guidelines
Others
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Collaborative Institutional Training Initiative Certificate
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A Letter of Support from the Organization
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Copy of Institutional Review Board Approval Letter
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Appendix H
Post-Education Intervention Questionnaire (PEIQ)
Chlamydia screening (CDC guidelines, 2015) for asymptomatic patients
Routine annual screening for sexually active women and for all pregnant women
under 25 years of age
Others;
Women including pregnant older than 25 who are at risk (women who have
new, multiple sexual partners, and history of chlamydia)
Men in high prevalence clinical settings, and MSM
1. If a female patient who is sexually active and younger than 25 years old had no
symptoms associated with chlamydia/GC, would you still order STD screen?
1) Yes
2) No
3) Yes, if I remember the CDC guidelines
2. If no, would you please answer the question why you don’t order STDs even though
the CDC guideline recommends to screen for female asymptomatic patients who are
younger than 25 years old?
1)
2)
3)
4)
5)
6)
7)
8)
9)

The patient is asymptomatic
Not necessary based on my professional decision
Unaware of the CDC guidelines
No time; too busy
Wasting time/money
I don’t want to order
ER is not the right place, may be GYN/Primary clinic
A patient has conditions more serious than chlamydia
Others

10 If an asymptomatic patient has a history of positive STDs, are you going to screen?
1) Yes
2) No

